01.13.21 Financial Times: Get vaccine new variant ready Share: Share on Linkedin Share on Twitter Share on Facebook GreenLight Biosciences explain to the Financial Times how messenger RNA can help get the Covid-19 vaccine new variant ready. GreenLight Biosciences spoke to the Financial Times about making sure that any vaccine is new variant ready for Covid-19. An extract from the article is below: Andrey Zarur, chief executive of Greenlight Biosciences, a biotech company that is making a messenger RNA vaccine, said it made sense to design new vaccines to “prepare for further drift”.“Then you have a better chance of your new vaccine continuing to protect against new variants,” Mr Zarur said. Read the full article here. Find out more about how GreenLight manufactures RNA here.